insider schreef:allen daarheen !
http://finance.yahoo.com/news/aradigm-p ... 00989.html" onclick="window.open(this.href);return false;

This company just began a Phase III clinical trial partnered with Grifols that is going to take two years to complete. Sit back and wait because it is a regulatory pathway that has no shortcuts. Anyone who thought they would double their money before 2016 is delusional. The fastest three NDA filings for "breakthrough drugs" in the last 10 years were 26-27 months after Phase III clinicals began. Do not invest in biotech or biopharma if they are trialing their first preparation if you want results before three years. The important part of this company is they have a proprietary compound and Grifols has the cash to support the trials. If this stock goes down to $7 or lower, pick up shares but hold them for your kids or grandkids.

all things come to those who wait

insider schreef:@Iommeke : op de MB van ARDM dien je de posts van rehdvm2004 te lezen : hij is iemand die -als gepensioneerd veearts en onderzoeker- weet waarover hij spreekt.
Hier is een post van hem :

This company just began a Phase III clinical trial partnered with Grifols that is going to take two years to complete. Sit back and wait because it is a regulatory pathway that has no shortcuts. Anyone who thought they would double their money before 2016 is delusional. The fastest three NDA filings for "breakthrough drugs" in the last 10 years were 26-27 months after Phase III clinicals began. Do not invest in biotech or biopharma if they are trialing their first preparation if you want results before three years. The important part of this company is they have a proprietary compound and Grifols has the cash to support the trials. If this stock goes down to $7 or lower, pick up shares but hold them for your kids or grandkids.

Hier een uitspraak die u gerust moet stellen :

all things come to those who wait